Melanie Braun
Labor LS
Referent:innen
Dr Armin Hauk
Sartorius Stedim Biotech
Stefan Gärtner
Labor LS
Dr Katja Aschermann
Astator
Raphael Parusel
TETEC
Dr Ana Kuschel
West Pharmaceutical Services
Anna Liznar
PathoQuest
Zielsetzung
This live online training is designed to address challenges such as mitigating risks of contamination, degradation and supply chain disruption. It provides industry professionals with the knowledge and skills needed to ensure compliance and optimise their processes for handling biological raw materials and active pharmaceutical ingredients.
Background
Raw materials, excipients and other products used in the manufacture of biologics must be well understood in terms of their role in the manufacturing process. Particularly in a GMP regulated environment, these raw materials, components and excipients require thorough control for consistent quality.
Therefore, all critical quality attributes should be known and appropriate risk mitigation and control strategies should be established. Since there is currently less written guidance on risk-based management of biological raw materials, European Pharmaceutical Enterprises, EBE, has prepared a concept paper entitled “Management and Control of Raw Materials Used in the Manufacture of Biological Medicinal Products.”
But other approaches can also be helpful - a look at Annex 1 for products that need to be sterile or have a low bioburden claim. Or the QbD approaches for consistent quality of products.
Background
Raw materials, excipients and other products used in the manufacture of biologics must be well understood in terms of their role in the manufacturing process. Particularly in a GMP regulated environment, these raw materials, components and excipients require thorough control for consistent quality.
Therefore, all critical quality attributes should be known and appropriate risk mitigation and control strategies should be established. Since there is currently less written guidance on risk-based management of biological raw materials, European Pharmaceutical Enterprises, EBE, has prepared a concept paper entitled “Management and Control of Raw Materials Used in the Manufacture of Biological Medicinal Products.”
But other approaches can also be helpful - a look at Annex 1 for products that need to be sterile or have a low bioburden claim. Or the QbD approaches for consistent quality of products.
Hintergrund
Tuesday, 10 March 2026, 09.00 h – 15.30 h
Wednesday, 11 March 2026, 09.00 h – 15.00 h
All times mentioned are CET.
Wednesday, 11 March 2026, 09.00 h – 15.00 h
All times mentioned are CET.
Zielgruppe
This training will be highly valuable for:
- Laboratory managers
- Quality control managers
- Analytical scientists
- Senior laboratory personnel
- QA Units
- Qualified Persons (QPs)
It is designed for professionals from biopharmaceutical companies, ATMP developers, and manufacturers. Additionally, the training is relevant for employees of contract laboratories involved in method development, control testing, and quality assurance.
Technical Requirements
We use Webex for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Fees (per delegate plus VAT)
ECA Members € 1,890
APIC Members € 1,990
Non-ECA Members € 2,090
EU GMP Inspectorates € 1,045
The conference fee is payable in advance after receipt of invoice.
Presentations/Certificate
The presentations will be made available to you prior to the Live Online Training as PDF files. After the event, you will automatically receive your certificate of participation.
Conference language
The official conference language will be English.
Contacts:
Questions regarding content:
Mr Clemens Mundo (Operations Director) +49(0)62 21/84 44 42, mundo@concept-heidelberg.de
Questions regarding organisation:
Ms Isabell Helm (Organisation Manager), +49(0)62 21/84 44 49, helm@concept-heidelberg.de.
Programm
Gesamtes Programm als PDF herunterladen
Classification and Regulatory Aspects of Biological Raw Materials
(Katja Aschermann)
(Katja Aschermann)
- Starting materials
- Biological raw materials
- Novel excipients
QbD Approach to Registration of Raw Materials
(Katja Aschermann)
(Katja Aschermann)
- Introduction to the QbD approach
- Target material profiles and critical quality attributes
- Development of a QbD approach for raw materials
- Examples
Process-related Leachables
(Armin Hauk)
(Armin Hauk)
- What are Process Equipment Related Leachables (PERLs)?
- Bioprocessing using Single Use Systems (SUS)
- Regulatory requirements
- The dedicated concerns - Extractables Studies for SUS
- The extrapolation of extractables data to PERL exposure data
- PERL in safety and risk assessment
- PERL mitigation concepts
The Search for Ideal Biologics Containment
(Ana Kuschel)
(Ana Kuschel)
- Materials types and requirements
- Selection criteria considerations
- Regulatory landspace overview
- Current solutions for biologics
Raw Material Qualification for Cell Therapies
(Katja Aschermann)
(Katja Aschermann)
- From risk profile to material qualification
- Examples
- Quality control of raw materials
Microbiological Safety: Protection Strategies for Product Quality and Health
(Melanie Braun)
(Melanie Braun)
- Basic principles of industrial hygiene
- Risk factors for microbiological contamination
- Case studies
- Prevention strategies, monitoring and controls
Viral Contamination Risk Control Strategy
(Anna Liznar)
(Anna Liznar)
- Regulatory aspects in viral safety of biological raw materials
- Viral risk identification with NGS
- Considerations for viral safety of biological raw materials used in ATMP production
Rapid Microbiological Control of Raw Materials
(Stefan Gärtner)
(Stefan Gärtner)
- General requirements for (rapid) bioburden, sterility and endotoxin Tests
- Handling of small and/or complex sample volumes
- Design of validation studies
- Overview of different rapid methods for different matrices
Suppliers – Selection and Qualification
(Raphael Parusel)
(Raphael Parusel)
- Sourcing
- Development of a supply chain
- Qualification
- Auditing
- Monitoring
Effective Storage Solutions
(Raphael Parusel)
(Raphael Parusel)
- GMP warehouse structure
- Documentation
- Storage of medicinal products and medical devices
- Hygiene and Monitoring
- Implementation of ERP systems
- GDP
| ECA-Member*: | € 1890,- |
| Non ECA Member*: | € 2090,- |
| EU/GMP Inspectorates*: | € 1045,- |
| APIC Member Discount*: | € 1990,- |
Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.
* auch unkompliziert per Kreditkarte bezahlbar
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
Weitere Termine online
Weitere Termine online nicht verfügbar
This course is part of the GMP Certification Programme "ECA Certified Biotech Manager"
Haben Sie noch Fragen?
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
E-Mail: info@concept-heidelberg.de
Teilnehmerstimmen
Seminarprogramm als PDFTeilnehmerstimmen - das sagen andere über unsere Seminare:
